Deleted Tweets From Scott Gottlieb, R-D.C.

#FDA is committed to a comprehensive approach to substantially reducing the morbidity and mortality associated with combustible tobacco and preventing youth initiation on any tobacco product https://t.co/cA5v57zjdS

RT @FDA_Track: FDA authorizes first fully interoperable continuous #glucose monitoring system, streamlines review pathway for simi… https://t.co/1stVm4u7Py

RT @SGottliebFDA: #FDA shares the belief that tobacco products, including e-cigs, should never be marketed to, sold to, or used by ki… https://t.co/9Jh2W8mZgB

RT @megtirrell: The grilling begins 9amET! If you can’t make it in person, tune in to our livestream at https://t.co/zafIV8hEOW #HealthyRet… QT @SGottliebFDA: Looking forward to joining @megtirrell at the @CNBC #HealthyReturns conference today to discuss #FDA’s policies on… https://t.co/2RpbH0NBch)

Looking forward to joining @megtirrell at the @CNBC #HealthyReturns conference today to discuss #FDA’s policies on tobacco regulation, drug pricing, and the outlook for our public health agenda

#FDA is committed to advancing policies that will help foster the development of safe and effective innovation that can improve health. In the coming months we’ll publish a new suite of policies related to advancing the area of gene therapy https://t.co/K

RT @BerkeleyJr: FDA chief @SGottliebFDA speaking on consolidation in the health-care space #HealthyReturns https://t.co/CHS2ThSJlw

The @Surgeon_General has had tough struggles and his strength in sharing them with us is inspirational to those also confronting serious illness. His leadership echos widely and I admire him very much. I wish Lacey a speedy recovery https://t.co/FFNEpNWyr QT @Surgeon_General: My wife Lacey was recently diagnosed with metastatic melanoma. As I write this, she is in surgery to treat nodal re… https://t.co/rLreTSeIwG)

RT @CNBC: LIVE: @SGottliebFDA on the agency’s plan to take on drug prices, Big Tobacco and the opioid crisis with @megtirrell… https://t.co/VI7EuApUjc

RT @dgingery: #Biosimilars and #USP monographs have been a thorny issue for some time. This looks like the latest concern... https://t.co/3… QT @SGottliebFDA: We hope @USPharmacopeia will carefully consider complexities involved as they evaluate their proposal for biologica… https://t.co/SeU4MaDhBe)

Suppliers, including specialty pharmacies, are often owned by PBMs, and they must end restrictive agreements with brand drug companies that impede generic competition. The PBMs can’t claim they aren’t involved when they own specialty pharmacies that are.

Agreements between specialty pharmacies and drug companies to curtail generic developer access to drug samples are very concerning – and the largest specialty pharmacies are owned by the largest PBMs. https://t.co/WggzGThhJC

RT @US_FDA: FDA Commissioner @SGottliebFDA gave the keynote address at the 41st Annual National Food Policy Conference. He disc… https://t.co/BypbZspY9j

New paper by @US_FDA & @NIDAnews on need for new medications to treat opioid use disorders. #FDA has two guidances coming to facilitate development of new drugs/formulations that could have attributes that are better tailored to patient needs: https:/

As part of efforts to explore new endpoints for medication-assisted treatments that help achieve therapeutic benefit, @US_FDA is holding a patient-focused drug development meeting in April to hear directly from individuals with opioid use disorder: https:

RT @US_FDA: “FDA regulates 80% of our country’s food supply, and we take this important role in our nation’s health very seriou… https://t.co/TKoK8nER9t

Like our efforts around tobacco, @US_FDA comprehensive new nutrition strategy is one of our greatest opportunities to have a profound and generational impact on human health. https://t.co/AnOhC21qtI https://t.co/nlAjqHwkuY

RT @FDADeviceInfo: FDA posts key takeaways from our recent #DigitalHealth workshop https://t.co/xx4lzix17K #FDAPrecert #MedicalDevice

RT @US_FDA: FDA Commissioner @SGottliebFDA introduced FDA’s Nutrition Innovation Strategy @ today’s #CFAFPC. Learn more about t… https://t.co/4LqFJeyavF

#FDA’s comprehensive nutrition plan, announced today, is a fundamentally new strategic initiative and reframing of the agency’s view on importance of nutrition as a tool for public health — and a detailed new agenda for how we will build on that mission h

#FDA is committed to a comprehensive approach to substantially reducing the morbidity and mortality associated with combustible tobacco and preventing youth initiation on any tobacco product https://t.co/cA5v57zjdS

RT @FDA_Track: FDA authorizes first fully interoperable continuous #glucose monitoring system, streamlines review pathway for simi… https://t.co/1stVm4u7Py

RT @SGottliebFDA: #FDA shares the belief that tobacco products, including e-cigs, should never be marketed to, sold to, or used by ki… https://t.co/9Jh2W8mZgB

RT @megtirrell: The grilling begins 9amET! If you can’t make it in person, tune in to our livestream at https://t.co/zafIV8hEOW #HealthyRet… QT @SGottliebFDA: Looking forward to joining @megtirrell at the @CNBC #HealthyReturns conference today to discuss #FDA’s policies on… https://t.co/2RpbH0NBch)

Looking forward to joining @megtirrell at the @CNBC #HealthyReturns conference today to discuss #FDA’s policies on tobacco regulation, drug pricing, and the outlook for our public health agenda

#FDA is committed to advancing policies that will help foster the development of safe and effective innovation that can improve health. In the coming months we’ll publish a new suite of policies related to advancing the area of gene therapy https://t.co/K

RT @BerkeleyJr: FDA chief @SGottliebFDA speaking on consolidation in the health-care space #HealthyReturns https://t.co/CHS2ThSJlw

The @Surgeon_General has had tough struggles and his strength in sharing them with us is inspirational to those also confronting serious illness. His leadership echos widely and I admire him very much. I wish Lacey a speedy recovery https://t.co/FFNEpNWyr QT @Surgeon_General: My wife Lacey was recently diagnosed with metastatic melanoma. As I write this, she is in surgery to treat nodal re… https://t.co/rLreTSeIwG)

RT @CNBC: LIVE: @SGottliebFDA on the agency’s plan to take on drug prices, Big Tobacco and the opioid crisis with @megtirrell… https://t.co/VI7EuApUjc

RT @dgingery: #Biosimilars and #USP monographs have been a thorny issue for some time. This looks like the latest concern... https://t.co/3… QT @SGottliebFDA: We hope @USPharmacopeia will carefully consider complexities involved as they evaluate their proposal for biologica… https://t.co/SeU4MaDhBe)

Suppliers, including specialty pharmacies, are often owned by PBMs, and they must end restrictive agreements with brand drug companies that impede generic competition. The PBMs can’t claim they aren’t involved when they own specialty pharmacies that are.

Agreements between specialty pharmacies and drug companies to curtail generic developer access to drug samples are very concerning – and the largest specialty pharmacies are owned by the largest PBMs. https://t.co/WggzGThhJC

RT @US_FDA: FDA Commissioner @SGottliebFDA gave the keynote address at the 41st Annual National Food Policy Conference. He disc… https://t.co/BypbZspY9j

New paper by @US_FDA & @NIDAnews on need for new medications to treat opioid use disorders. #FDA has two guidances coming to facilitate development of new drugs/formulations that could have attributes that are better tailored to patient needs: https:/

As part of efforts to explore new endpoints for medication-assisted treatments that help achieve therapeutic benefit, @US_FDA is holding a patient-focused drug development meeting in April to hear directly from individuals with opioid use disorder: https:

RT @US_FDA: “FDA regulates 80% of our country’s food supply, and we take this important role in our nation’s health very seriou… https://t.co/TKoK8nER9t

Like our efforts around tobacco, @US_FDA comprehensive new nutrition strategy is one of our greatest opportunities to have a profound and generational impact on human health. https://t.co/AnOhC21qtI https://t.co/nlAjqHwkuY

RT @FDADeviceInfo: FDA posts key takeaways from our recent #DigitalHealth workshop https://t.co/xx4lzix17K #FDAPrecert #MedicalDevice

RT @US_FDA: FDA Commissioner @SGottliebFDA introduced FDA’s Nutrition Innovation Strategy @ today’s #CFAFPC. Learn more about t… https://t.co/4LqFJeyavF

#FDA’s comprehensive nutrition plan, announced today, is a fundamentally new strategic initiative and reframing of the agency’s view on importance of nutrition as a tool for public health — and a detailed new agenda for how we will build on that mission h